Executive Director, Global Strategic Marketing – Early Inflammation Pipeline and Strategy, Commercial Team Lead (CTL)

Job Description

At Gilead our pursuit of a healthier world for all people has yielded a cure for hepatitis C, revolutionary improvements in HIV treatment and prevention as well as advancements in therapies for viral and inflammatory diseases and certain cancers.
We set and achieve bold ambitions in our fight against the world’s most devastating diseases, united in our commitment to confronting the largest public health challenges of our day and improving the lives of patients for generations to come.
As a Executive Director Global Strategic Marketing , you will be responsible for the development of global marketing strategies for the early inflammation pipeline. You will be a “player/coach” in that you will lead a team early pipeline marketers and you will provide key strategic input into the commercialization of Gilead’s emerging portfolio of inflammation assets, including serving as Commercial Team Lead for some key programs. In this capacity you will be responsible for the development of the commercialization strategies to optimize the value of these assets.
In addition to providing commercial leadership of the inflammation pipeline assets, this role will also lead GSM team in the commercial assessments for inflammation business development opportunities, determining commercial value and alignment with Gilead’s inflammation therapeutic area strategy. The successful candidate, in close collaboration with cross-functional partners, will lead the development of commercial strategies, including development of TPP, commercial input into clinical trial design, new indications and lifecycle management opportunities, to drive the development and implementation of integrated commercialization strategies.
This position will be based in Foster City, CA.

Key Responsibilities

Reporting to the Vice President, Global Commercial Product Strategy, LIVE, you will:

• Develop and execute the commercial strategic vision across Gilead’s early inflammation pipeline, balancing near-term and long-term priorities.
• Represent global commercial on a Project Strategy Team and help shape clinical / regulatory strategy and planning in close partnership with cross-functional colleagues.
• This individual will establish and lead a cross functional global, early commercial team (eCT) as well as an to build integrated global strategies that meet global market, regulatory and payer needs as the pipeline assets advance toward registration, approval and launch.
• Create strong and close working relationship with a few key Gilead markets, including ex-US markets, with whom you will partner for the development of global commercial strategies.
• Develop the global brand profile and key marketing deliverables, including global brand vision and value proposition, accounting for competitive landscape and potential to differentiate competitively.
• Conduct strategic marketing activities including market and competitive research and product positioning in close collaboration with cross-commercial disciplines.
• Identify actionable insights based on market research and ensure that the product / brand addresses unmet need areas.
• Your ultimate benchmark will be the successful development and execution of global commercial strategies that maximizes the overall value of our assets, while ensuring patient access across the product lifecycle.